Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 382165, 9 pages
http://dx.doi.org/10.1155/2015/382165
Review Article

Role of Nutritional Factors at the Early Life Stages in the Pathogenesis and Clinical Course of Type 1 Diabetes

1Department of Health and Nutrition, The University of Shimane, Matsue, Shimane 690-0044, Japan
2Department of Developmental Biology, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan

Received 26 June 2014; Revised 2 November 2014; Accepted 3 November 2014

Academic Editor: Kjersti S. Rønningen

Copyright © 2015 Yukiko Kagohashi and Hiroki Otani. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Atkinson and N. K. MacLaren, “The pathogenesis of insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 331, pp. 1428–1436, 1994. View at Google Scholar
  2. G. S. Eisenbarth, “Type I diabetes mellitus. A chronic autoimmune disease,” The New England Journal of Medicine, vol. 314, no. 21, pp. 1360–1368, 1986. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Tisch and H. McDevitt, “Insulin-dependent diabetes mellitus,” Cell, vol. 85, no. 3, pp. 291–297, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Nokoff and M. Rewers, “Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals,” Annals of the New York Academy of Sciences, vol. 1281, no. 1, pp. 1–15, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. L. Mehers and K. M. Gillespie, “The genetic basis for type 1 diabetes,” British Medical Bulletin, vol. 88, no. 1, pp. 115–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. F. M. Egro, “Why is type 1 diabetes increasing?” Journal of Molecular Endocrinology, vol. 51, no. 1, pp. R1–R13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Hanafusa and A. Imagawa, “Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 1, pp. 36–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Spagnuolo, A. Patti, G. Sebastiani, L. Nigi, and F. Dotta, “The case for virus-induced type 1 diabetes,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 20, no. 4, pp. 292–298, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Skarsvik, J. Puranen, J. Honkanen et al., “Decreased in vitro type 1 immune response against coxsackie virus B4 in children with type 1 diabetes,” Diabetes, vol. 55, no. 4, pp. 996–1003, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Lönnrot, K. Salminen, M. Knip et al., “Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group,” Journal of Medical Virology, vol. 61, no. 2, pp. 214–220, 2000. View at Publisher · View at Google Scholar
  11. R. Iwakiri, S. Nagafuchi, E. Kounoue et al., “Cyclosporin A enhances Streptozocin-induced diabetes in CD-1 mice,” Experientia, vol. 43, no. 3, pp. 324–327, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Carter, T. Gomes, X. Camacho, D. N. Juurlink, B. R. Shah, and M. M. Mamdani, “Risk of incident diabetes among patients treated with statins: population based study,” British Medical Journal, vol. 346, no. 7911, Article ID f2610, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. A. D. Bolzán and M. S. Bianchi, “Genotoxicity of Streptozotocin,” Mutation Research, vol. 512, no. 2-3, pp. 121–134, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nakamura, S. Nagafuchi, K. Yamaguchi, and R. Takaki, “The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice,” Diabetes, vol. 33, no. 9, pp. 894–900, 1984. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Iwakiri and S. Nagafuchi, “Inhibition of streptozocin-induced insulitis and diabetes with lobenzarit in CD-1 mice,” Diabetes, vol. 38, no. 5, pp. 558–561, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. K. B. Johnsen, T. M. Poulsen, B. Z. Christiansen et al., “Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus,” The Lancet, vol. 2, no. 8411, pp. 1083–1086, 1984. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Atkinson, M. A. Bowman, K.-J. Kao et al., “Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes,” The New England Journal of Medicine, vol. 329, no. 25, pp. 1853–1858, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Karjalainen, J. M. Martin, M. Knip et al., “A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 327, no. 5, pp. 302–307, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Martin, B. Trink, D. Daneman, H.-M. Dosch, and B. Robinson, “Milk proteins in the etiology of insulin-dependent diabetes mellitus (IDDM),” Annals of Medicine, vol. 23, no. 4, pp. 447–452, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Ceriello, A. Novials, E. Ortega et al., “Vitamin C further improves the protective effect of glucagon-like peptide-1 on acute hypoglycemia-induced oxidative stress, inflammation, and endothelial dysfunction in type 1 diabetes,” Diabetes Care, vol. 36, no. 12, pp. 4104–4108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. A. W. Greeley, M. Katsumata, L. Yu et al., “Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice,” Nature Medicine, vol. 8, no. 4, pp. 399–402, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Kagohashi, J. Udagawa, N. Abiru, M. Kobayashi, K. Moriyama, and H. Otani, “Maternal factors in a model of type 1 diabetes differentially affect the development of insulitis and overt diabetes in offspring,” Diabetes, vol. 54, no. 7, pp. 2026–2031, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Kagohashi, J. Udagawa, K. Moriyama, and H. Otani, “Maternal environment affects endogenous virus induction in the offspring of type 1 diabetes model non-obese diabetic mice,” Congenital Anomalies, vol. 45, no. 3, pp. 80–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Jayasimhan, K. P. Mansour, and R. M. Slattery, “Advances in our understanding of the pathophysiology of type 1 diabetes: Lessons from the NOD mouse,” Clinical Science, vol. 126, no. 1, pp. 1–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. C. F. Verge, R. Gianani, E. Kawasaki et al., “Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies,” Diabetes, vol. 45, no. 3, pp. 926–933, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Fujita, H. Fujino, and K. Nonaka, “Retrovirus-like particles in pancreatic B-cells of NOD (non-obese diabetic) mice,” Biomedical Research, vol. 5, no. 1, pp. 67–70, 1984. View at Google Scholar · View at Scopus
  27. H. Tsumura, M. Miyazawa, S. Ogawa, J. Z. Wang, Y. Ito, and K. Shimura, “Detection of endogenous retrovirus antigens in NOD mouse pancreatic β-cells,” Laboratory Animals, vol. 32, no. 1, pp. 86–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. J. M. Norris, B. Beaty, G. Klingensmith et al., “Lack of association between early exposure to cow's milk protein and β- cell autoimmunity: diabetes autoimmunity study in the young (DAISY),” Journal of the American Medical Association, vol. 276, no. 8, pp. 609–614, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Marjamäki, S. Niinistö, M. G. Kenward et al., “Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring,” Diabetologia, vol. 53, no. 8, pp. 1599–1607, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. L. C. Stene and G. Joner, “Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study,” American Journal of Clinical Nutrition, vol. 78, no. 6, pp. 1128–1134, 2003. View at Google Scholar · View at Scopus
  31. L. C. Stene, J. Ulriksen, P. Magnus, and G. Joner, “Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring,” Diabetologia, vol. 43, no. 9, pp. 1093–1098, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. C. M. Fronczak, A. E. Barón, H. P. Chase et al., “In utero dietary exposures and risk of islet autoimmunity in children,” Diabetes Care, vol. 26, no. 12, pp. 3237–3242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Norris, X. Yin, M. M. Lamb et al., “Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes,” The Journal of the American Medical Association, vol. 298, no. 12, pp. 1420–1428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Norris, “Infant and childhood diet and type 1 diabetes risk: recent advances and prospects,” Current Diabetes Reports, vol. 10, no. 5, pp. 345–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. R. Miller, X. Yin, J. Seifert et al., “Erythrocyte membrane omega-3 fatty acid levels and omega-3 fatty acid intake are not associated with conversion to type 1 diabetes in children with islet autoimmunity: the Diabetes Autoimmunity Study in the Young (DAISY),” Pediatric Diabetes, vol. 12, no. 8, pp. 669–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Peppa, C. He, M. Hattori, R. McEvoy, F. Zheng, and H. Vlassara, “Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice,” Diabetes, vol. 52, no. 6, pp. 1441–1448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Fu, J. Yuskavage, and D. Liu, “Dietary flavonol epicatechin prevents the onset of type 1 diabetes in nonobese diabetic mice,” Journal of Agricultural and Food Chemistry, vol. 61, no. 18, pp. 4303–4309, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Kagohashi, N. Abiru, M. Kobayashi, M. Hashimoto, O. Shido, and H. Otani, “Maternal dietary n-6/n-3 fatty acid ratio affects type 1 diabetes development in the offspring of non-obese diabetic mice,” Congenital Anomalies, vol. 50, no. 4, pp. 212–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. S. Skyler, “Primary and secondary prevention of type 1 diabetes,” Diabetic Medicine, vol. 30, no. 2, pp. 161–169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. D. B. Jump, “Fatty acid regulation of gene transcription,” Critical Reviews in Clinical Laboratory Sciences, vol. 41, no. 1, pp. 41–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. N. Din, D. E. Newby, and A. D. Flapan, “Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment,” British Medical Journal, vol. 328, no. 7430, pp. 30–35, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. P. C. Calder, “n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic,” Lipids, vol. 38, no. 4, pp. 343–352, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Yaqoob, “Fatty acids and the immune system: from basic science to clinical applications,” Proceedings of the Nutrition Society, vol. 63, no. 1, pp. 89–104, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. Á. Gil, “Polyunsaturated fatty acids and inflammatory diseases,” Biomedicine & Pharmacotherapy, vol. 56, no. 8, pp. 388–396, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. P. Simopoulos, “Omega-3 fatty acids in inflammation and autoimmune diseases,” Journal of the American College of Nutrition, vol. 21, no. 6, pp. 495–505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. J. J. Pestka, “N-3 Polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 82, no. 4-6, pp. 251–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Lumia, P. Luukkainen, H. Tapanainen et al., “Dietary fatty acid composition during pregnancy and the risk of asthma in the offspring,” Pediatric Allergy and Immunology, vol. 22, no. 8, pp. 827–835, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. H. P. Chase, E. Lescheck, L. Rafkin-Mervis et al., “The Type 1 Diabetes TrialNet NIP Study Group. Nutritional intervention to prevent (NIP) type 1 diabetes: a pilot trial,” Infant, Child, & Adolescent Nutrition, vol. 1, pp. 98–107, 2009. View at Google Scholar
  49. B. I. Nwaru, M. Erkkola, M. Lumia et al., “Maternal intake of fatty acids during pregnancy and allergies in the offspring,” British Journal of Nutrition, vol. 108, no. 4, pp. 720–732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. P. Simopoulos, “The importance of the ratio of omega-6/omega-3 essential fatty acids,” Biomedicine and Pharmacotherapy, vol. 56, no. 8, pp. 365–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Kankaanpää, K. Nurmela, A. Erkkilä et al., “Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 56, no. 7, pp. 633–638, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Uauy-Dagach and P. Mena, “Nutritional role of omega-3 fatty acids during the perinatal period,” Clinics in Perinatology, vol. 22, no. 1, pp. 157–175, 1995. View at Google Scholar · View at Scopus
  53. A. Fagen and J. Scheidler, “Meals to go,” Journal of Renal Nutrition, vol. 10, no. 4, pp. 215–230, 2000. View at Google Scholar · View at Scopus
  54. S. Schmid, K. Koczwara, S. Schwinghammer, V. Lampasona, A.-G. Ziegler, and E. Bonifacio, “Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice,” Clinical Immunology, vol. 111, no. 1, pp. 108–118, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Kagohashi and H. Otani, “Dietary EFA ratio of the gestation period affects type 1 diabetes development in the offspring,” Experimental Animals, vol. 60, p. S122, 2011. View at Google Scholar
  56. Y. Kagohashi, H. Kameyama, Y. Fujihara et al., “The effect of dietary EFA ratio and composition on the development of type 1 diabetes in the offspring of NOD mice,” Congenital Anomalies, vol. 51, no. 4, p. A18, 2011. View at Google Scholar
  57. G. Kuriya, T. Uchida, S. Akazawa et al., “Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse,” Diabetologia, vol. 56, no. 8, pp. 1773–1780, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. M. J. Allen, Y. Y. Fan, J. M. Monk et al., “N-3 PUFAs reduce T-helper 17 cell differentiation by decreasing responsiveness to interleukin-6 in isolated mouse splenic CD4+ T cells,” The Journal of Nutrition, vol. 144, no. 8, pp. 1306–1313, 2014. View at Publisher · View at Google Scholar
  59. J. M. Norris, M. Kroehl, T. E. Fingerlin et al., “Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the Diabetes Autoimmunity Study in the Young,” Diabetologia, vol. 57, no. 2, pp. 295–304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Kagohashi and H. Otani, “Dietary EFA ratio of the gestation period affects type 1 diabetes development in the offspring,” Experimental Animals, vol. 60, no. 3, p. S122, 2011. View at Google Scholar
  61. D. J. P. Barker and C. Osmond, “Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales,” The Lancet, vol. 1, no. 8489, pp. 1077–1081, 1986. View at Google Scholar · View at Scopus
  62. P. P. Silveira, A. K. Portella, M. Z. Goldani, and M. A. Barbieri, “Developmental origins of health and disease (DOHaD),” Jornal de Pediatria, vol. 83, no. 6, pp. 494–504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. Y. Kagohashi and H. Otani, “Maternal intake of essential fatty acid affects development of type 1 diabetes in the offspring,” Journal of Lipid Nutrition, vol. 22, no. 1, pp. 35–43, 2013. View at Publisher · View at Google Scholar
  64. Y. Kagohashi and H. Otani, “Maternal environmental factors and the development of type 1 diabetes,” Diabetes and Pregnancy, vol. 7, pp. 23–29, 2007. View at Google Scholar